Viewing Study NCT00464893


Ignite Creation Date: 2025-12-25 @ 1:06 AM
Ignite Modification Date: 2025-12-25 @ 11:18 PM
Study NCT ID: NCT00464893
Status: COMPLETED
Last Update Posted: 2013-12-04
First Post: 2007-04-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection
Sponsor: Neovii Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module